- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Paediatric growth hormone deficiency (GHD)
- Meeting Date: July 2023
- Public Summary Document (PSD) July 2023 PBAC Meeting - (PDF 1MB)
- Public Summary Document (PSD) July 2023 PBAC Meeting - (Word 199KB)
Somapacitan – July 2023
Somapacitan: Injection 5 mg in 1.5 mL pre-filled pen, Injection 10 mg in 1.5 mL pre-filled pen Injection 15 mg in 1.5 mL pre-filled pen; Sogroya®
Last updated
27 October 2023